Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
In this study, we observed the effects of different uterine leiomyoma driver mutations to tumor DNA methylation, chromatin activity and gene expression, to form a comprehensive view on the epigenetic consequences of the mutations.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001006278 | Illumina HiSeq 4000 | 10 | |
EGAD00001006279 | Illumina HiSeq 2500 | 76 | |
EGAD00010001923 | Illumina HiSeq 2500 | 23 | |
EGAD00010001924 | Illumina HiSeq 2500/NovaSeq 6000 | 438 | |
EGAD00010001925 | Oxford Nanopore | 202 | |
EGAD00010001926 | Illumina Infinium HumanCore-24/HumanOmni2.5-8 | 2186 | |
EGAD00010001927 | Illumina HiSeq 2500/NovaSeq 6000 | 438 | |
EGAD00010001928 | Illumina HiSeq 4000 | 31 | |
EGAD00010002051 | Illumina HiSeq 2500 | 48 | |
EGAD00010002155 | Illumina HiSeq 2500 | 5 |
Publications | Citations |
---|---|
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
Hum Mol Genet 32: 2023 1063-1071 |
2 |
Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
Am J Hum Genet 110: 2023 460-474 |
4 |